FASN and malignant colon neoplasm: Here we show that by employing two drugs clinically tested in the 80s, which are inhibitors of glycolysis –lonidamine-22,23 and glutaminolysis –DON-24–26, plus the well-known inhibitor of FASN -orlistat-10,21, effective in vitro and in vivo effects against colon cancer cells are found.